Basit öğe kaydını göster

Quetiapine Fumarate Extended-release Tablet Formulation Design Using Artificial Neural Networks

dc.contributor.authorAksu, Buket
dc.contributor.authorMesut, Burcu
dc.contributor.authorOzcelik, Esher
dc.contributor.authorOzsoy, Yildiz
dc.date.accessioned2021-03-04T19:53:42Z
dc.date.available2021-03-04T19:53:42Z
dc.date.issued2017
dc.identifier.citationOzcelik E., Mesut B., Aksu B., Ozsoy Y., "Quetiapine Fumarate Extended-release Tablet Formulation Design Using Artificial Neural Networks", TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES, cilt.14, ss.213-221, 2017
dc.identifier.othervv_1032021
dc.identifier.otherav_91f7073e-bcfd-4f29-bccc-9a5fb177e86d
dc.identifier.urihttp://hdl.handle.net/20.500.12627/98461
dc.identifier.urihttps://doi.org/10.4274/tjps.97720
dc.description.abstractObjectives: This design study was implemented within the scope of the quality by design approach, which included the "International Conference on Harmonization" guidelines. We evaluated the quality of a modified-release tablet formulation of quetiapine fumarate, which was designed using artificial neural networks (ANN), and determined a new formulation that was similar to the reference product.
dc.language.isoeng
dc.subjectTemel Bilimler
dc.subjectEczacılık
dc.subjectYaşam Bilimleri
dc.subjectTemel Eczacılık Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.titleQuetiapine Fumarate Extended-release Tablet Formulation Design Using Artificial Neural Networks
dc.typeMakale
dc.relation.journalTURKISH JOURNAL OF PHARMACEUTICAL SCIENCES
dc.contributor.departmentİstanbul Üniversitesi , Eczacılık Fakültesi , Eczacılık Teknolojisi
dc.identifier.volume14
dc.identifier.issue3
dc.identifier.startpage213
dc.identifier.endpage221
dc.contributor.firstauthorID247770


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster